• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lmo2 (LIM-Domain-Only 2) Modulates Sphk1 (Sphingosine Kinase) and Promotes Endothelial Cell Migration.Lmo2(仅含LIM结构域2)调节鞘氨醇激酶1(Sphk1)并促进内皮细胞迁移。
Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1860-1868. doi: 10.1161/ATVBAHA.117.309609. Epub 2017 Aug 3.
2
LIM Domain Only 2 Regulates Endothelial Proliferation, Angiogenesis, and Tissue Regeneration.仅含LIM结构域蛋白2调控内皮细胞增殖、血管生成和组织再生。
J Am Heart Assoc. 2016 Oct 6;5(10):e004117. doi: 10.1161/JAHA.116.004117.
3
Fli1 cells transcriptional analysis reveals an Lmo2-Prdm16 axis in angiogenesis.Fli1 细胞转录分析揭示了血管生成中的 Lmo2-Prdm16 轴。
Proc Natl Acad Sci U S A. 2021 Aug 3;118(31). doi: 10.1073/pnas.2008559118.
4
LDB2 regulates the expression of DLL4 through the formation of oligomeric complexes in endothelial cells.LDB2 通过在血管内皮细胞中形成寡聚复合物来调节 DLL4 的表达。
BMB Rep. 2018 Jan;51(1):21-26. doi: 10.5483/bmbrep.2018.51.1.140.
5
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.去乙酰化激活 LMO2 对于造血和 T-ALL 白血病发生是不可或缺的。
Blood. 2019 Oct 3;134(14):1159-1175. doi: 10.1182/blood.2019000095. Epub 2019 Jul 31.
6
The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish.转录因子Scl和Lmo2在斑马鱼成血管细胞的发育过程中共同发挥作用。
Blood. 2007 Mar 15;109(6):2389-98. doi: 10.1182/blood-2006-02-003087. Epub 2006 Nov 7.
7
FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.FHL-2通过与鞘氨醇激酶-1相互作用抑制血管内皮生长因子诱导的磷脂酰肌醇3-激酶/蛋白激酶B激活。
Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):909-14. doi: 10.1161/ATVBAHA.108.178541. Epub 2009 Mar 26.
8
Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.人参皂苷化合物 K 通过调节人脐静脉内皮细胞中的鞘氨醇激酶-1 抑制血管生成。
Arch Pharm Res. 2014;37(9):1183-92. doi: 10.1007/s12272-014-0340-6. Epub 2014 Apr 1.
9
GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.GATA2 和 Lmo2 通过直接转录调控神经纤毛蛋白-2 来控制血管生成和淋巴管生成。
Angiogenesis. 2013 Oct;16(4):939-52. doi: 10.1007/s10456-013-9370-9. Epub 2013 Jul 28.
10
Angiomotin-like2 gene (amotl2) is required for migration and proliferation of endothelial cells during angiogenesis.血管生成素样 2 基因(amotl2)在血管生成过程中内皮细胞的迁移和增殖中是必需的。
J Biol Chem. 2011 Nov 25;286(47):41095-104. doi: 10.1074/jbc.M111.296806. Epub 2011 Sep 20.

引用本文的文献

1
Sphingolipid Metabolism and Signalling Pathways in Heart Failure: From Molecular Mechanism to Therapeutic Potential.心力衰竭中的鞘脂代谢与信号通路:从分子机制到治疗潜力
J Inflamm Res. 2025 Apr 23;18:5477-5498. doi: 10.2147/JIR.S515757. eCollection 2025.
2
Dynamics of Endothelial Cell Diversity and Plasticity in Health and Disease.内皮细胞多样性和可塑性在健康和疾病中的动态变化。
Cells. 2024 Jul 29;13(15):1276. doi: 10.3390/cells13151276.
3
FLI-1-driven regulation of endothelial cells in human diseases.FLI-1 驱动的人类疾病中的血管内皮细胞调控。
J Transl Med. 2024 Aug 6;22(1):740. doi: 10.1186/s12967-024-05546-4.
4
Sphk1 deficiency induces apoptosis and developmental defects and premature death in zebrafish.Sphk1 缺陷导致斑马鱼凋亡和发育缺陷,并导致其过早死亡。
Fish Physiol Biochem. 2023 Aug;49(4):737-750. doi: 10.1007/s10695-023-01215-3. Epub 2023 Jul 18.
5
Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer.靶向 SPHK1/PBX1 轴诱导非小细胞肺癌细胞周期停滞。
Int J Mol Sci. 2022 Oct 22;23(21):12741. doi: 10.3390/ijms232112741.
6
Effects of sphingolipid metabolism disorders on endothelial cells.鞘脂代谢紊乱对血管内皮细胞的影响。
Lipids Health Dis. 2022 Oct 13;21(1):101. doi: 10.1186/s12944-022-01701-2.
7
Whole-Transcriptome Sequencing Analyses of Nuclear Antixoxidant-1 in Endothelial Cells: Role in Inflammation and Atherosclerosis.全转录组测序分析内皮细胞中的核抗氧化剂-1:在炎症和动脉粥样硬化中的作用。
Cells. 2022 Sep 18;11(18):2919. doi: 10.3390/cells11182919.
8
Endothelial versus pronephron fate decision is modulated by the transcription factors Cloche/Npas4l, Tal1, and Lmo2.内皮细胞与前肾命运的决定受转录因子Cloche/Npas4l、Tal1和Lmo2的调控。
Sci Adv. 2022 Sep 2;8(35):eabn2082. doi: 10.1126/sciadv.abn2082. Epub 2022 Aug 31.
9
The transcription factor complex LMO2/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis.转录因子复合物LMO2/TAL1在出芽血管生成中调节分支和内皮细胞迁移。
Sci Rep. 2022 May 4;12(1):7226. doi: 10.1038/s41598-022-11297-3.
10
Endothelial Notch signaling directly regulates the small GTPase RND1 to facilitate Notch suppression of endothelial migration.内皮细胞 Notch 信号直接调节小 GTPase RND1,以促进 Notch 抑制内皮细胞迁移。
Sci Rep. 2022 Jan 31;12(1):1655. doi: 10.1038/s41598-022-05666-1.

本文引用的文献

1
LIM Domain Only 2 Regulates Endothelial Proliferation, Angiogenesis, and Tissue Regeneration.仅含LIM结构域蛋白2调控内皮细胞增殖、血管生成和组织再生。
J Am Heart Assoc. 2016 Oct 6;5(10):e004117. doi: 10.1161/JAHA.116.004117.
2
Sphingosine-1-Phosphate Signaling in Endothelial Disorders.内皮疾病中的鞘氨醇-1-磷酸信号传导
Curr Atheroscler Rep. 2016 Jun;18(6):31. doi: 10.1007/s11883-016-0586-1.
3
Dynamic Gene Regulatory Networks Drive Hematopoietic Specification and Differentiation.动态基因调控网络驱动造血细胞特化与分化。
Dev Cell. 2016 Mar 7;36(5):572-87. doi: 10.1016/j.devcel.2016.01.024. Epub 2016 Feb 25.
4
The LMO2 oncogene regulates DNA replication in hematopoietic cells.LMO2致癌基因调节造血细胞中的DNA复制。
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1393-8. doi: 10.1073/pnas.1515071113. Epub 2016 Jan 13.
5
Maternal and Zygotic Sphingosine Kinase 2 Are Indispensable for Cardiac Development in Zebrafish.母体和合子鞘氨醇激酶2对斑马鱼心脏发育至关重要。
J Biol Chem. 2015 Jun 12;290(24):14841-51. doi: 10.1074/jbc.M114.634717. Epub 2015 Apr 23.
6
Sphingosine 1-phosphate signalling.鞘氨醇 1-磷酸信号转导。
Development. 2014 Jan;141(1):5-9. doi: 10.1242/dev.094805.
7
The role of PR-Set7 in replication licensing depends on Suv4-20h.PR-Set7 在复制许可中的作用依赖于 Suv4-20h。
Genes Dev. 2012 Dec 1;26(23):2580-9. doi: 10.1101/gad.195636.112. Epub 2012 Nov 14.
8
Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.针对疾病中的鞘氨醇激酶/1-磷酸鞘氨醇途径:鞘氨醇激酶抑制剂综述
Biochim Biophys Acta. 2013 Jan;1831(1):157-66. doi: 10.1016/j.bbalip.2012.07.002. Epub 2012 Jul 16.
9
The outs and the ins of sphingosine-1-phosphate in immunity.鞘氨醇-1-磷酸在免疫中的正反两面。
Nat Rev Immunol. 2011 Jun;11(6):403-15. doi: 10.1038/nri2974. Epub 2011 May 6.
10
The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720.鞘氨醇-1-磷酸转运蛋白 SPNS2 是免疫调节剂 FTY720 磷酸化形式的转运蛋白。
J Biol Chem. 2011 Jan 21;286(3):1758-66. doi: 10.1074/jbc.M110.171116. Epub 2010 Nov 17.

Lmo2(仅含LIM结构域2)调节鞘氨醇激酶1(Sphk1)并促进内皮细胞迁移。

Lmo2 (LIM-Domain-Only 2) Modulates Sphk1 (Sphingosine Kinase) and Promotes Endothelial Cell Migration.

作者信息

Matrone Gianfranco, Meng Shu, Gu Qilin, Lv Jie, Fang Longhou, Chen Kaifu, Cooke John P

机构信息

From the Department of Cardiovascular Sciences, Houston Methodist Research Institute, TX.

出版信息

Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1860-1868. doi: 10.1161/ATVBAHA.117.309609. Epub 2017 Aug 3.

DOI:10.1161/ATVBAHA.117.309609
PMID:28775072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5637529/
Abstract

OBJECTIVE

(LIM-domain-only)2 transcription factor is involved in hematopoiesis and vascular remodeling. (sphingosine kinase)1 phosphorylates sphingosine to S1P (sphingosine-1-phosphate). We hypothesized that regulates to promote endothelial cell (EC) migration and vascular development. APPROACH AND RESULTS: and knockdown (KD) were performed in ) zebrafish and in human umbilical vein EC. Rescue of phenotypes or overexpression of these factors were achieved using mRNA encoding or . EC proliferation in vivo was assessed by BrdU (bromodeoxyuridine) immunostaining and fluorescence-activated cell sorter analysis of dissociated ) embryos. Cell migration was assessed by scratch assay in human umbilical vein EC and mouse aortic rings. interactions with promoter were assessed by ChIP-PCR (chromatin immunoprecipitation-polymerase chain reaction). or KD reduced number and length of intersegmental vessels. There was no reduction in the numbers of GFP (green fluorescent protein) ECs after KD. However, reduced numbers of BrdUGFP nuclei were observed along the dysmorphic intersegmental vessels, accumulating instead at the sprouting origin of the intersegmental vessels. This anomaly was likely because of impaired EC migration, which was confirmed in migration assays using KD human umbilical vein ECs and mouse aortic rings. Both in vivo and in vitro, KD reduced gene expression, associated with less binding to the promoter as assessed by ChIP-PCR. mRNA rescued the KD phenotype.

CONCLUSIONS

Our data showed that is necessary for gene expression in ECs. KD reduced - gene interaction, impaired intersegmental vessels formation, and reduced cell migration. We identified for the first time as downstream effector of .

摘要

目的

(仅含LIM结构域)2转录因子参与造血和血管重塑。鞘氨醇激酶1将鞘氨醇磷酸化为S1P(1-磷酸鞘氨醇)。我们推测[此处原文有缺失信息未明确指出推测的主体]调节[此处原文有缺失信息未明确指出被调节的对象]以促进内皮细胞(EC)迁移和血管发育。

方法与结果

在斑马鱼和人脐静脉内皮细胞中进行[此处原文有缺失信息未明确指出具体进行敲低的对象]敲低(KD)。使用编码[此处原文有缺失信息未明确指出具体因子]的mRNA实现这些因子的表型挽救或过表达。通过BrdU(溴脱氧尿苷)免疫染色和对解离的[此处原文有缺失信息未明确指出具体胚胎]胚胎进行荧光激活细胞分选分析来评估体内EC增殖。通过人脐静脉内皮细胞和小鼠主动脉环的划痕试验评估细胞迁移。通过染色质免疫沉淀 - 聚合酶链反应(ChIP - PCR)评估[此处原文有缺失信息未明确指出具体因子]与[此处原文有缺失信息未明确指出具体启动子]启动子的相互作用。[此处原文有缺失信息未明确指出具体因子]或[此处原文有缺失信息未明确指出具体因子]KD减少了节间血管的数量和长度。[此处原文有缺失信息未明确指出具体因子]KD后GFP(绿色荧光蛋白)内皮细胞数量没有减少。然而,在畸形的节间血管中观察到BrdU - GFP细胞核数量减少,反而在节间血管的发芽起源处积累。这种异常可能是由于内皮细胞迁移受损,这在使用[此处原文有缺失信息未明确指出具体因子]KD人脐静脉内皮细胞和小鼠主动脉环的迁移试验中得到证实。在体内和体外,[此处原文有缺失信息未明确指出具体因子]KD均降低了[此处原文有缺失信息未明确指出具体基因]的基因表达,如通过ChIP - PCR评估的那样,这与[此处原文有缺失信息未明确指出具体因子]与[此处原文有缺失信息未明确指出具体启动子]启动子的结合减少有关。[此处原文有缺失信息未明确指出具体因子]mRNA挽救了[此处原文有缺失信息未明确指出具体因子]KD表型。

结论

我们的数据表明[此处原文有缺失信息未明确指出具体因子]对于内皮细胞中[此处原文有缺失信息未明确指出具体基因]的基因表达是必需的。[此处原文有缺失信息未明确指出具体因子]KD减少了[此处原文有缺失信息未明确指出具体因子] - [此处原文有缺失信息未明确指出具体基因]的相互作用,损害了节间血管形成,并减少了细胞迁移。我们首次确定[此处原文有缺失信息未明确指出具体因子]为[此处原文有缺失信息未明确指出具体因子]的下游效应物。